Nachrichten zur Merck & Co. Inc. Aktie

Merck & Co: Anlagevotum bestätigt

New York (www.aktiencheck.de) - Rating-Update: Mara Goldstein, Analystin von Mizuho Securities USA, stuft die Aktie von Merck & Co Inc.…

Mercks MK-0616 Cuts LDL-C in Hypercholesterolemia in Phase 2b Study >MRK

Merck's MK-0616 Cuts LDL-C in Hypercholesterolemia in Phase 2b Study >MRK...…

Merck (MRK) Stock Sinks As Market Gains: What You Should Know

Merck (MRK) closed at $106.88 in the latest trading session, marking a -0.12% move from the prior day....…

Is Trending Stock Merck & Co., Inc. (MRK) a Buy Now?

Merck (MRK) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what…

Merck, AstraZeneca say FDA panel to review application for cancer drug

...March 2 (Reuters) - Merck & Co Inc and AstraZeneca PLC said......…

Merck: Phase 3 KEYNOTE-671 Trial With KEYTRUDA Meets One Of Its Dual Primary Endpoints

KENILWORTH (NJ) (dpa-AFX) - Merck (MRK) announced that the Phase 3 KEYNOTE-671 trial investigating KEYTRUDA met one of its dual…

Merck: Phase 3 Keytruda Study Hits Key Goal in Non-Small Cell Lung Cancer >MRK

Merck: Phase 3 Keytruda Study Hits Key Goal in Non-Small Cell Lung Cancer >MRK...…

Merck to discontinue Keytruda combination study for prostate cancer

...(Reuters) - Merck & Co on Tuesday said it will stop a late-stage......…

NVIDIA-Aktie nach Zahlen im Aufwind - Fresenius will sich auf Kerngeschäft konzentrieren

Wien (www.aktiencheck.de) - Als Reaktion auf das Zahlenwerk von Mittwochabend konnte die Aktie von NVIDIA (ISIN: US67066G1040, WKN: 918422, Ticker-Symbol:…

Merck & Co: "overweight"

New York (www.aktiencheck.de) - Rating-Update: Die Analysten von J.P. Morgan Securities stufen die Aktie von Merck & Co Inc. (ISIN:…

Form 10-K Merck & Co., Inc. For: Dec 31

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Merck: CHMP Recommends Against Approval Of Lagevrio For Treatment Of Certain Adults With COVID-19

KENILWORTH (NJ) (dpa-AFX) - Merck & Co Inc. (MRK) and Ridgeback Biotherapeutics said Friday that the Committee for Medicinal Products…

Merck: CHMP Recommends Against OK of Lagevrio for Certain Adults With Covid-19 >MRK

Merck: CHMP Recommends Against OK of Lagevrio for Certain Adults With Covid-19 >MRK...…

Merck and Ridgeback Biotherapeutics to appeal advisory panel to EU regulator’s decision to recommend refusing authorization of their COVID antiviral

Merck & Co. Inc. MRK and privately held Ridgeback Biotherapeutics said Friday a panel advising the European regulator has recommended…

Moderna stock pops after cancer-vaccine candidate gets FDA breakthrough designation

Moderna Inc. MRNAand Merck Inc. MRK shares increased in after-hours trading Wednesday after the pharmaceutical companies announced that a cancer-vaccine…

Lung Cancer Drugs Global Market Report 2023

NEW YORK, Feb. 21, 2023 /PRNewswire/ -- Major players in the lung cancer market are Bristol-Myers Squibb Company, Merck &…

Antiglaucoma Drugs Global Market Report 2023

NEW YORK, Feb. 20, 2023 /PRNewswire/ -- Major players in the antiglaucoma drugs market are Aerie Pharmaceuticals, Inc., Allergan, Novartis…

Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?

Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could…

Merck (MRK) Gets Priority Tag for Antiviral Drug Prevymis sNDA

The FDA grants priority review designation to Mercks (MRK) sNDA seeking expanded use of Prevymis. The PDUFA date is Jun…

Moderna fallen nach Studiendaten: Zinssorgen belasten US-Börsen

Die Inflationssorgen lassen die Anleger an der Wall Street zum Wochenschluss nicht los. Der Dow wird unter anderem vom Pharmakonzern…

FDA to Review Two Expansions of Mercks Prevymis >MRK

FDA to Review Two Expansions of Merck's Prevymis >MRK...…

Antiobesity Global Market Report 2023

NEW YORK, Feb. 16, 2023 /PRNewswire/ -- Major players in the anti-obesity market are F. Hoffmann-La Roche AG, GlaxoSmithKline PLC,…

Insiderhandel: President, Human Health Int?l verkauft Aktien von Merck & Company im Wert von 541.101$

Romanelli, Joseph - Vorstand - Tag der Transaktion: 2023-02-15...…

Insiderhandel: EVP, Chief HR Officer verkauft Aktien von Merck & Company im Wert von 198.017$

Mizell, Steven - Vorstand - Tag der Transaktion: 2023-02-13...…

DTP Vaccines Global Market Report 2023

NEW YORK, Feb. 13, 2023 /PRNewswire/ -- Major players in the DTP vaccines market are Merck & Co, Sanofi, GSK,…

Merck & Co: Die Konferenz des American College of Cardiology 2023 als ein wichtiger Katalysator? Aktienanalyse

Zürich (www.aktiencheck.de) - Merck & Co-Aktienanalyse von Analyst Trung Huynh von der Credit Suisse: Trung Huynh, Analyst von der Credit Suisse,…

Merck & Co: Solides Ergebnis, aber verhaltener Ausblick - Aktienanalyse

Wien (www.aktiencheck.de) - Merck & Co-Aktienanalyse von der Raiffeisen Bank International AG: Benedikt-Luka Antic, Analyst der Raiffeisen Bank International AG (RBI),…

Merck & Co: Kursziel angehoben

Charlotte, NC (www.aktiencheck.de) - Rating-Update: Robyn Karnauskas, Analystin von Truist, stuft die Aktie von Merck & Co Inc. (ISIN: US58933Y1055, WKN:…

Insiderhandel: EVP, Chief HR Officer verkauft Aktien von Merck & Company im Wert von 535.007$

Mizell, Steven - Vorstand - Tag der Transaktion: 2023-02-09...…

Merck & Co., Inc.: Merck: Women in Science? Absolutely.

NORTHAMPTON, MA / ACCESSWIRE / February 9, 2023 / Women scientists have historically been underrepresented in the field of process…

Aligos Therapeutics Announces Strategic Reprioritization of NASH and COVID-19 Programs and Confirms Key Timelines and Extension of Cash Runway to Year-End 2024

– Pipeline reprioritization emphasizes NASH and COVID-19 assets, ALG-055009 and ALG-097558, plus key ongoing collaborations, including the Merck & Co.…

Insiderhandel: EVP, Chief HR Officer verkauft Aktien von Merck & Company im Wert von 462.473$

Mizell, Steven - Vorstand - Tag der Transaktion: 2023-02-06...…

Wellmarker Bio Announces Clinical Trial Collaboration with MSD to evaluate WM-A1-3389 in combination with KEYTRUDA® (pembrolizumab)

Wellmarker Bio is pleased to sign a clinical collaboration and supply agreement with MSD (Merck & Co., Inc., Rahway, NJ,…

ROUNDUP: Merck & Co rechnet mit schwächerem Jahr - Aktie unter Druck

RAHWAY (dpa-AFX) - Der US-Pharmakonzern Merck & Co (Merck) dürfte nach kräftigen Zuwächsen im vergangenen Jahr den Rückwärtsgang einlegen. Der…

+++ Geschäftszahlen im Newsblog +++: Corona-Boom bei Merck & Co lässt nach – Ferrari erwartet kräftiges Gewinnplus

Corona-Boom bei Merck & Co lässt nach +++ Harley-Davidson verdient deutlich mehr +++ Shell erzielt Rekordgewinn +++ Die Geschäftszahlen…

Dow gibt Gewinne ab, Nasdaq 100 deutlich im Plus, Microsoft, Meta, Salesforce und Align Technology enorm stark, Merck & Co schwach – der Tag an der Wall Street

Gute Zahlen und ein überzeugender Ausblick von Meta haben am Donnerstag die Erholungsrally der US-Techwerte nochmals beschleunigt. Während die Meta-Aktien…

dpa-AFX ProFeed